Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomic Study to Predict Toxicity and Response in Gastric Cancer Patients Treated With Adjuvant Chemotherapy

NCT01470404 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01470404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01470404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomic Study to Predict Toxicity and Response in Gastric Cancer Patients Treated With Adjuvant Chemotherapy
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
July 10, 2008
Completion date
July 10, 2013
Enrollment
792 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer